- Home
- KRUS vs ELVN Comparison
KRUS vs ELVN Comparison
Compare KRUS & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRUS
- ELVN
- Stock Information
- Founded
- KRUS 2008
- ELVN 2016
- Country
- KRUS United States
- ELVN United States
- Employees
- KRUS N/A
- ELVN N/A
- Industry
- KRUS Restaurants
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- KRUS Consumer Discretionary
- ELVN Health Care
- Exchange
- KRUS Nasdaq
- ELVN Nasdaq
- Market Cap
- KRUS 1.1B
- ELVN 1.2B
- IPO Year
- KRUS 2019
- ELVN 2020
- Fundamental
- Price
- KRUS $77.61
- ELVN $17.69
- Analyst Decision
- KRUS Buy
- ELVN Strong Buy
- Analyst Count
- KRUS 9
- ELVN 5
- Target Price
- KRUS $94.56
- ELVN $41.20
- AVG Volume (30 Days)
- KRUS 269.5K
- ELVN 371.3K
- Earning Date
- KRUS 07-08-2025
- ELVN 08-19-2025
- Dividend Yield
- KRUS N/A
- ELVN N/A
- EPS Growth
- KRUS N/A
- ELVN N/A
- EPS
- KRUS N/A
- ELVN N/A
- Revenue
- KRUS $269,327,000.00
- ELVN N/A
- Revenue This Year
- KRUS $20.49
- ELVN N/A
- Revenue Next Year
- KRUS $20.15
- ELVN N/A
- P/E Ratio
- KRUS N/A
- ELVN N/A
- Revenue Growth
- KRUS 18.76
- ELVN N/A
- 52 Week Low
- KRUS $40.03
- ELVN $13.30
- 52 Week High
- KRUS $110.66
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- KRUS 42.11
- ELVN 34.68
- Support Level
- KRUS $81.33
- ELVN $18.18
- Resistance Level
- KRUS $86.46
- ELVN $20.26
- Average True Range (ATR)
- KRUS 5.23
- ELVN 1.14
- MACD
- KRUS -1.13
- ELVN -0.38
- Stochastic Oscillator
- KRUS 7.97
- ELVN 4.86
About KRUS Kura Sushi USA Inc.
Kura Sushi USA Inc is a technology-enabled restaurant concept serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. It offers several dishes, including Dashi Olive Salmon, Tomago, Sweet Shrimp, Tuna, Garlic Tuna Steak, and Salmon, among others.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.